(Q43630479)

English

Study of the toxicological effect of mitomycin C in mice: alteration on the biodistribution of radiopharmaceuticals used for renal evaluations

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Study of the toxicological effect of mitomycin C in mice: alteration on the biodistribution of radiopharmaceuticals used for renal evaluations (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

M L Gomes

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

D M de Mattos

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

R de Souza Freitas

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

R J Bezerra

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M Bernardo-Filho

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Human & Experimental Toxicology

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

193-197

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Adverse reactions and drug interactions with radiopharmaceuticals

1 reference

https://api.crossref.org/works/10.1191%2F096032701678766840

21 January 2018

Drug interactions with radiopharmaceuticals

1 reference

https://api.crossref.org/works/10.1191%2F096032701678766840

21 January 2018

Non-enzymatic and enzymatic activation of mitomycin C: identification of a unique cytosolic activity

1 reference

https://api.crossref.org/works/10.1191%2F096032701678766840

21 January 2018

Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1191%2F096032701678766840

21 January 2018

Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1191%2F096032701678766840

21 January 2018

Effects of a novel pyridylsulphonyl thiazole derivative, FR115092, on autoimmune and mitomycin C-induced thrombocytopenia in mice

1 reference

https://api.crossref.org/works/10.1191%2F096032701678766840

21 January 2018

A model to evaluate the biological effect of natural products: vincristine action on the biodistribution of radiopharmaceuticals in BALB/c female mice

1 reference

https://api.crossref.org/works/10.1191%2F096032701678766840

21 January 2018

Radiopharmaceutical-related pitfalls and artifacts

1 reference

https://api.crossref.org/works/10.1191%2F096032701678766840

21 January 2018

Role of mitomycin C in the development of late bowel toxicity foloowing chemoradiation for locally advanced carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1191%2F096032701678766840

21 January 2018

Radiopharmaceuticals for renal studies: Evaluation of protein binding

1 reference

https://api.crossref.org/works/10.1191%2F096032701678766840

21 January 2018

Identifiers

10.1191/096032701678766840

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43630479&oldid=2101990076"